Beijing, Beijing, China Everest Venture Capital is the famous VC, which was founded in 2007. The leading representative office of defined VC is situated in the Beijing. The venture was found in Asia in China.
The fund is constantly included in 2-6 deals per year. The important activity for fund was in 2019. Considering the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The average startup value when the investment from Everest Venture Capital is 100-500 millions dollars. The common things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Everest Venture Capital, startups are often financed by V Star Capital, Qiming Venture Partners, IDG Ventures. The meaningful sponsors for the fund in investment in the same round are Zhuhai Science & Technology Venture Capital, Z&H Investment, Y&R Capital. In the next rounds fund is usually obtained by SIG China (SIG Asia Investments), Cowin Capital, Z&H Investment.
The current fund was established by Jiancong Xiao, Kai Shen, Xianhong Liang, Yunxi Li, Yuping Wang.
We can highlight the next thriving fund investment areas, such as Robotics, STEM Education. Among the most popular portfolio startups of the fund, we may highlight Sublue Ocean Science & Technology, Afanti, Yunxuetang. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has exact preference in some founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - China.
Related Funds
Funds with similar focus
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Huazhang Intelligent | $15M | 08 Oct 2023 | Nanjing, Jiangsu, China | ||
Youyun | $30M | 15 Sep 2023 | Hangzhou, Zhejiang, China | ||
NanoVista | 13 Sep 2023 | Haidian, Beijing, China | |||
Medical Source | $15M | 04 Aug 2023 | Kunshan, Anhui, China | ||
ICE Bioscience InC. | $15M | 03 Aug 2023 | - | ||
Xinhengrui Medical | $15M | 17 Jul 2023 | Minhang, Shanghai, China | ||
Proxverse | $1M | 20 Jun 2023 | Jingan, Shanghai, China | ||
Zhongneng Chuang | $15M | 19 Jun 2023 | Yangzhou, Jiangsu, China | ||
Wuxi Xinxiang | 08 Jun 2023 | Dangtu County, Anhui, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Huazhang Intelligent | $15M | 08 Oct 2023 | Nanjing, Jiangsu, China | ||
Youyun | $30M | 15 Sep 2023 | Hangzhou, Zhejiang, China | ||
NanoVista | 13 Sep 2023 | Haidian, Beijing, China | |||
Medical Source | $15M | 04 Aug 2023 | Kunshan, Anhui, China | ||
ICE Bioscience InC. | $15M | 03 Aug 2023 | - | ||
Xinhengrui Medical | $15M | 17 Jul 2023 | Minhang, Shanghai, China | ||
Proxverse | $1M | 20 Jun 2023 | Jingan, Shanghai, China | ||
Zhongneng Chuang | $15M | 19 Jun 2023 | Yangzhou, Jiangsu, China | ||
Wuxi Xinxiang | 08 Jun 2023 | Dangtu County, Anhui, China |
